Home > Insider Trading > Filing (0001593968-21-001029)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887359	Vericel Corp	VCEL	Biological Products, (No Disgnostic Substances) (2836)	943096597

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1313403	Dominick Colangelo	C/O Vericel Corporation 64 Sidney Street Cambridge MA 02139	President And Ceo	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-03-29	1,010	$51.36	206,540	No	4	S	Direct
Common Stock	Disposition	2021-03-29	15,552	$51.09	190,988	No	4	S	Direct
Common Stock	Disposition	2021-03-29	10,313	$50.93	180,675	No	4	S	Direct
Common Stock	Disposition	2021-03-29	13,125	$50.94	167,550	No	4	S	Direct
Common Stock	Acquisiton	2021-03-30	7,500	$25.80	175,050	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-03-30	7,500	$0.00	7,500	$25.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
47,501		2023-03-06	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
The Reporting Person has elected to exercise and hold these shares at this time.
These options, representing the right to purchase 55,001 shares, became exercisable on March 6, 2014, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal monthly installments over three years thereafter, contingent upon continued service to the Company.